These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Antiaggregatory and anticoagulant effects of oligoamines. 12. Alkyl- and arylalkyl- derivatives of putrescine, spermidine and spermine]. Rehse K; Puchert E; Leissring S Arch Pharm (Weinheim); 1990 May; 323(5):287-94. PubMed ID: 2383171 [TBL] [Abstract][Full Text] [Related]
26. Comparison between in vitro lipid peroxidation in fresh sheep platelets and peroxidative processes during sheep platelet ageing under storage at 4 degrees C. Martín-Valmaseda EM; Sánchez-Yagüe J; Rodríguez MC; Gómez FP; Llanillo M Biochim Biophys Acta; 1999 Jul; 1419(2):313-24. PubMed ID: 10407082 [TBL] [Abstract][Full Text] [Related]
27. Oxidative inactivation of human and sheep platelet membrane-associated phosphotyrosine phosphatase activity. Hernández-Hernández A; Sánchez-Yagüe J; Martín-Valmaseda EM; Llanillo M Free Radic Biol Med; 1999 May; 26(9-10):1218-30. PubMed ID: 10381193 [TBL] [Abstract][Full Text] [Related]
28. Influence of dietary fatty acids on membrane fluidity and activation of rat platelets. Heemskerk JW; Feijge MA; Kalafusz R; Hornstra G Biochim Biophys Acta; 1989 Aug; 1004(2):252-60. PubMed ID: 2752022 [TBL] [Abstract][Full Text] [Related]
29. Acute membrane effects of trimetazidine in human platelets. Devynck MA; Le Quan Sang KH; Joulin Y; Mazeaud M Eur J Pharmacol; 1993 Apr; 245(2):105-10. PubMed ID: 8387923 [TBL] [Abstract][Full Text] [Related]
30. Effects of alcohols on fluorescence anisotropies of diphenylhexatriene and its derivatives in bovine blood platelets: relationships of the depth-dependent change in membrane fluidity by alcohols with their effects on platelet aggregation and adenylate cyclase activity. Kitagawa S; Hirata H Biochim Biophys Acta; 1992 Nov; 1112(1):14-8. PubMed ID: 1329963 [TBL] [Abstract][Full Text] [Related]
31. Membrane-destabilizing properties of C2-ceramide may be responsible for its ability to inhibit platelet aggregation. Simon CG; Gear AR Biochemistry; 1998 Feb; 37(7):2059-69. PubMed ID: 9485333 [TBL] [Abstract][Full Text] [Related]
32. Tetrandrine differentially inhibits aggregation and ATP-release of rat platelets. Chen YY; Kwan CY; Hui SC Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):105-8. PubMed ID: 9772654 [TBL] [Abstract][Full Text] [Related]
33. HA-29: an inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets. Lin CH; Kuo SC; Huang LJ; Huang TF; Teng CM Thromb Res; 1992 Apr; 66(1):61-73. PubMed ID: 1412184 [TBL] [Abstract][Full Text] [Related]
34. Is platelet phospholipid-dependent thrombin generation altered by acute myocardial infarction or aspirin? Rota S; Flynn PD; Wareham NJ; Baglin TP; Byrne CD Thromb Res; 1996 Aug; 83(4):329-38. PubMed ID: 8870177 [TBL] [Abstract][Full Text] [Related]
35. [Effect of 3,4-dihydroxyacetophenone on phospholipid components of platelet membrane in aged rats]. Peng DH; Shi L Yao Xue Xue Bao; 1995; 30(5):343-6. PubMed ID: 7660804 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of platelet aggregation by adenosine receptor agonists. Cristalli G; Vittori S; Thompson RD; Padgett WL; Shi D; Daly JW; Olsson RA Naunyn Schmiedebergs Arch Pharmacol; 1994 Jun; 349(6):644-50. PubMed ID: 7969516 [TBL] [Abstract][Full Text] [Related]
37. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo. Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956 [TBL] [Abstract][Full Text] [Related]
38. Structure-activity relationships of 4'-O-substituted 1-benzylisoquinolines with respect to their actions on the cell membrane of blood platelets and erythrocytes. Fujii T; Sato T; Tamura A; Kometani M; Nakao K; Fujitani K; Kodama K; Akasu M Eur J Pharmacol; 1988 Feb; 146(2-3):285-90. PubMed ID: 3131148 [TBL] [Abstract][Full Text] [Related]
39. Investigation of interaction of human platelet membrane components with anticoagulant drugs Abciximab and Eptifibatide. Gorodkiewicz E; Sankiewicz A; Figaszewski ZA Folia Histochem Cytobiol; 2010 Dec; 48(4):687-92. PubMed ID: 21478117 [TBL] [Abstract][Full Text] [Related]
40. Discontinuous alterations of platelet structure and function by bound, ionizable verapamil. Retzinger GS; Cohen L J Pharm Sci; 1992 Jan; 81(1):49-53. PubMed ID: 1619569 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]